Patients with chronic health issues showed significant improvements in the first three months of treatment with cannabis.
One in five Americans aged 50-60 have consumed cannabis in the last year - is the older generation recognising its benefits for health and wellbeing?
A new review has identified ‘multiple lines of evidence’ to support the use of cannabis-based medicines in Long Covid.
The report highlights 'concerns' over the lack of NHS access, but does not support further reform to cannabis laws.
The US Department of Health and Human Services has recommended that cannabis be classed as a lower risk drug. What does this mean for research, industry...
The findings of the review will inform a future RCT looking at the tolerability of cannabinoids in children with cancer.
The Home Office is being urged to protect the sector - and reassure millions of consumers - with better regulation.
The authors say those who used cannabis had higher neurocognition and social functioning over time.
Patients say medical cannabis reduces their symptoms, increases energy levels and improves job performance.
The UK saw the second highest number of clinical trials on cannabinoids in the last decade, the majority linked to GW Pharmaceuticals.